Syndecan-1 as an independent risk factor for the incidence of adverse cardiovascular events in patients having stage C and D heart failure with non-ischemic dilated cardiomyopathy

Patients with heart failure (HF) having non-ischemic dilated cardiomyopathy (DCM) have high mortality rates. Syndecan-1 is reportedly associated with cardiac fibrosis and inflammation. This study explored the role of syndecan-1 in patients with non-ischemic DCM. Patients with HF were prospectively e...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinica chimica acta 2019-03, Vol.490, p.63-68
Hauptverfasser:	Liu, Wei, Wang, Yuan, Zheng, Junmeng, Song, Deli, Zheng, Shuai, Ren, Lu, Wang, Yali, Yao, Yan, Wang, Yue, Liu, Yuanyuan, Bai, Rong, Dong, Jianzeng, Liu, Tong
Format:	Artikel
Sprache:	eng
Schlagworte:	Heart failure Non-ischemic dilated cardiomyopathy Syndecan-1
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!